US Stock MarketDetailed Quotes

DNTH Dianthus Therapeutics

Watchlist

24.810
+0.550+2.27%

Close Dec 10 16:00 ET

24.340
-0.470-1.89%

Pre 04:26 ET

734.30MMarket Cap-10857P/E (TTM)

Dianthus Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-112.84%-21.27M

-207.08%-14.53M

-45.28%-14.94M

-26.80%-36.86M

-33.93%-11.85M

-9.99M

-4.73M

-10.28M

-193.52%-29.07M

-8.85M

Net income from continuing operations

-70.52%-25.17M

-58.05%-17.61M

-93.93%-13.75M

-52.95%-43.56M

-4.42%-10.56M

---14.76M

---11.14M

---7.09M

-117.22%-28.48M

---10.12M

Depreciation and amortization

33.33%116K

32.14%111K

32.10%107K

141.50%355K

110.20%103K

--87K

--84K

--81K

--147K

--49K

Change In working capital

-32.23%2.6M

-95.24%289K

18.37%-2.82M

394.13%4.86M

-244.16%-1.59M

--3.84M

--6.07M

---3.45M

-152.61%-1.65M

--1.11M

-Change in receivables

-3,575.86%-1.01M

-121.64%-799K

-134.13%-398K

223.98%5.16M

123.70%273K

--29K

--3.69M

--1.17M

-181.98%-4.16M

---1.15M

-Change in prepaid assets

-120.00%-378K

-153.89%-291K

107.76%241K

119.49%123K

-1,148.92%-2.42M

--1.89M

--540K

--116K

-132.84%-631K

--231K

-Change in payables and accrued expense

631.05%5.65M

7.70%3.25M

36.86%-2.99M

-71.01%661K

-21.07%1.6M

--773K

--3.01M

---4.73M

-53.65%2.28M

--2.03M

-Change in other current assets

-81,100.00%-1.62M

-26,242.86%-1.83M

6,760.00%343K

-3,212.90%-1.03M

-5,861.11%-1.04M

---2K

--7K

--5K

-3.33%-31K

--18K

-Change in other working capital

-103.67%-42K

96.87%-37K

-88.89%-17K

-106.17%-55K

60.87%-9K

--1.15M

---1.18M

---9K

--891K

---23K

Cash from discontinued investing activities

Operating cash flow

-112.84%-21.27M

-207.08%-14.53M

-45.28%-14.94M

-26.80%-36.86M

-33.93%-11.85M

---9.99M

---4.73M

---10.28M

-193.52%-29.07M

---8.85M

Investing cash flow

Cash flow from continuing investing activities

-2,154.36%-259.36M

-94.65%1.17M

-130.37%-5.51M

133.86%20.25M

34.96%-8.24M

-11.51M

21.86M

18.13M

-181,169.70%-59.82M

-12.67M

Capital expenditure reported

61.54%-25K

19.05%-17K

-128.57%-32K

20.86%-110K

65.52%-10K

---65K

---21K

---14K

-321.21%-139K

---29K

Net investment purchase and sale

-2,166.95%-259.34M

-94.58%1.19M

-130.17%-5.48M

134.12%20.36M

34.89%-8.23M

---11.44M

--21.89M

--18.15M

---59.68M

---12.64M

Cash from discontinued investing activities

Investing cash flow

-2,154.36%-259.36M

-94.65%1.17M

-130.37%-5.51M

133.86%20.25M

34.96%-8.24M

---11.51M

--21.86M

--18.13M

-181,169.70%-59.82M

---12.67M

Financing cash flow

Cash flow from continuing financing activities

-99.79%296K

-2.2M

217.85M

38.17%133.57M

-4.87M

138.44M

548.31%96.68M

Net issuance payments of debt

--0

Net common stock issuance

--0

--230M

--72M

--0

--72M

--0

Net preferred stock issuance

----

--0

----

566.67%100M

--0

Proceeds from stock option exercised by employees

5,820.00%296K

--47K

--271K

--5K

--0

--5K

--0

Net other financing activities

--0

---2.24M

---12.42M

1,952.26%61.57M

---4.87M

----

-3,677.27%-3.32M

--0

Cash from discontinued financing activities

Financing cash flow

-99.79%296K

---2.2M

--217.85M

38.17%133.57M

---4.87M

--138.44M

--0

548.31%96.68M

--0

Net cash flow

Beginning cash position

677.71%314.24M

1,317.11%329.79M

758.29%132.39M

101.95%15.43M

325.94%157.35M

--40.41M

--23.27M

--15.43M

186.82%7.64M

--36.94M

Current changes in cash

-339.72%-280.34M

-190.79%-15.56M

2,415.60%197.4M

1,402.07%116.97M

-15.99%-24.96M

--116.94M

--17.13M

--7.85M

56.52%7.79M

---21.52M

End cash Position

-78.46%33.9M

677.71%314.24M

1,317.11%329.79M

758.29%132.39M

--157.35M

--40.41M

--23.27M

101.95%15.43M

--15.43M

Free cash flow

-111.71%-21.29M

-206.08%-14.55M

-45.40%-14.97M

-26.57%-36.97M

-33.60%-11.86M

---10.06M

---4.75M

---10.3M

-193.94%-29.21M

---8.88M

Currency Unit

USD

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-112.84%-21.27M	-207.08%-14.53M	-45.28%-14.94M	-26.80%-36.86M	-33.93%-11.85M	-9.99M	-4.73M	-10.28M	-193.52%-29.07M	-8.85M
Net income from continuing operations	-70.52%-25.17M	-58.05%-17.61M	-93.93%-13.75M	-52.95%-43.56M	-4.42%-10.56M	---14.76M	---11.14M	---7.09M	-117.22%-28.48M	---10.12M
Depreciation and amortization	33.33%116K	32.14%111K	32.10%107K	141.50%355K	110.20%103K	--87K	--84K	--81K	--147K	--49K
Change In working capital	-32.23%2.6M	-95.24%289K	18.37%-2.82M	394.13%4.86M	-244.16%-1.59M	--3.84M	--6.07M	---3.45M	-152.61%-1.65M	--1.11M
-Change in receivables	-3,575.86%-1.01M	-121.64%-799K	-134.13%-398K	223.98%5.16M	123.70%273K	--29K	--3.69M	--1.17M	-181.98%-4.16M	---1.15M
-Change in prepaid assets	-120.00%-378K	-153.89%-291K	107.76%241K	119.49%123K	-1,148.92%-2.42M	--1.89M	--540K	--116K	-132.84%-631K	--231K
-Change in payables and accrued expense	631.05%5.65M	7.70%3.25M	36.86%-2.99M	-71.01%661K	-21.07%1.6M	--773K	--3.01M	---4.73M	-53.65%2.28M	--2.03M
-Change in other current assets	-81,100.00%-1.62M	-26,242.86%-1.83M	6,760.00%343K	-3,212.90%-1.03M	-5,861.11%-1.04M	---2K	--7K	--5K	-3.33%-31K	--18K
-Change in other working capital	-103.67%-42K	96.87%-37K	-88.89%-17K	-106.17%-55K	60.87%-9K	--1.15M	---1.18M	---9K	--891K	---23K
Cash from discontinued investing activities
Operating cash flow	-112.84%-21.27M	-207.08%-14.53M	-45.28%-14.94M	-26.80%-36.86M	-33.93%-11.85M	---9.99M	---4.73M	---10.28M	-193.52%-29.07M	---8.85M
Investing cash flow
Cash flow from continuing investing activities	-2,154.36%-259.36M	-94.65%1.17M	-130.37%-5.51M	133.86%20.25M	34.96%-8.24M	-11.51M	21.86M	18.13M	-181,169.70%-59.82M	-12.67M
Capital expenditure reported	61.54%-25K	19.05%-17K	-128.57%-32K	20.86%-110K	65.52%-10K	---65K	---21K	---14K	-321.21%-139K	---29K
Net investment purchase and sale	-2,166.95%-259.34M	-94.58%1.19M	-130.17%-5.48M	134.12%20.36M	34.89%-8.23M	---11.44M	--21.89M	--18.15M	---59.68M	---12.64M
Cash from discontinued investing activities
Investing cash flow	-2,154.36%-259.36M	-94.65%1.17M	-130.37%-5.51M	133.86%20.25M	34.96%-8.24M	---11.51M	--21.86M	--18.13M	-181,169.70%-59.82M	---12.67M
Financing cash flow
Cash flow from continuing financing activities	-99.79%296K	-2.2M	217.85M	38.17%133.57M	-4.87M	138.44M	0	0	548.31%96.68M	0
Net issuance payments of debt	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Net common stock issuance	--0	--0	--230M	--72M	--0	--72M	--0	--0	--0	--0
Net preferred stock issuance	----	----	----	--0	----	----	----	----	566.67%100M	--0
Proceeds from stock option exercised by employees	5,820.00%296K	--47K	--271K	--5K	--0	--5K	--0	--0	--0	--0
Net other financing activities	--0	---2.24M	---12.42M	1,952.26%61.57M	---4.87M	----	----	----	-3,677.27%-3.32M	--0
Cash from discontinued financing activities
Financing cash flow	-99.79%296K	---2.2M	--217.85M	38.17%133.57M	---4.87M	--138.44M	--0	--0	548.31%96.68M	--0
Net cash flow
Beginning cash position	677.71%314.24M	1,317.11%329.79M	758.29%132.39M	101.95%15.43M	325.94%157.35M	--40.41M	--23.27M	--15.43M	186.82%7.64M	--36.94M
Current changes in cash	-339.72%-280.34M	-190.79%-15.56M	2,415.60%197.4M	1,402.07%116.97M	-15.99%-24.96M	--116.94M	--17.13M	--7.85M	56.52%7.79M	---21.52M
End cash Position	-78.46%33.9M	677.71%314.24M	1,317.11%329.79M	758.29%132.39M	758.29%132.39M	--157.35M	--40.41M	--23.27M	101.95%15.43M	--15.43M
Free cash flow	-111.71%-21.29M	-206.08%-14.55M	-45.40%-14.97M	-26.57%-36.97M	-33.60%-11.86M	---10.06M	---4.75M	---10.3M	-193.94%-29.21M	---8.88M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	--	--

Heat List

Overall

No Data